Variants in Vitamin D-related Genes and Prostate Cancer Risk in Black Men.

Area of Science:

• Genetics
• Oncology
• Nutritional Science

Background:

• Prostate cancer disproportionately affects Black men, who also exhibit lower vitamin D levels and unique genetic variations.
• Previous research on vitamin D and prostate cancer has largely excluded Black men.
• This study investigates vitamin D pathway genes in relation to prostate cancer risk specifically in Black men.

Purpose of the Study:

• To examine the association between genetic variants in six key vitamin D pathway genes and prostate cancer risk in Black men.
• To compare findings in Black men with existing data from White men.

Main Methods:

• Genome-wide association study data from approximately 10,000 prostate cancer cases and 10,000 controls among Black men, and over 85,000 cases and 91,000 controls among White men were analyzed.
• Sixty-nine candidate variants in six genes (GC, CYP27A1, CYP27B1, CYP24A1, VDR, and RXRA) were assessed.
• A stringent statistical significance threshold (P=0.000724) was applied to account for multiple comparisons.

Main Results:

• No significant associations were found between the tested variants in the vitamin D pathway genes and prostate cancer risk in Black men after adjusting for multiple comparisons.
• Suggestive, non-significant associations were observed for four variants in the RXRA and VDR genes in Black men (P<0.05).
• Two VDR variants showed positive associations with prostate cancer risk in the larger White cohort.

Conclusions:

• While suggestive associations were noted, no definitive link was established between the studied vitamin D pathway gene variants and prostate cancer risk in Black men.
• Larger sample sizes are required in future research to identify potential ancestry-specific genetic variants impacting prostate cancer risk in Black men.
• Further investigation into the complex relationship between vitamin D, genetics, and prostate cancer in diverse populations is warranted.